Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
boston blog main
5
×
boston top stories
depression
5
×
life sciences
national blog main
national top stories
biotech
new york blog main
new york top stories
boston
clinical trials
major depressive disorder
san francisco blog main
san francisco top stories
blackstone group
boulder/denver blog main
boulder/denver top stories
david goldstein
detroit blog main
detroit top stories
epilepsy
essential tremor
fda
indiana blog main
indiana top stories
kiran reddy
national
neuroscience
perimenopausal depression
praxis precision medicines
raleigh-durham blog main
raleigh-durham top stories
sage therapeutics
san diego blog main
san diego top stories
seattle blog main
seattle top stories
steven petrou
texas blog main
texas top stories
What
new
depression
drugs
genetic
medical
medicines
praxis
precision
research
way
aims
approval
backed
bio
biopharma
biotechs
brexanalone
cancer
cause
centers
central
ceo
cns
congress
congressional
crispr
cut
disorder
drug
emerged
epilepsy
event
executives
fda
feud
genes
group
guesswork
guide
helps
Language
unset
Current search:
depression
×
photo
×
" boston blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?